Clearside Biomedical, Inc. (CLSD): Price and Financial Metrics

Clearside Biomedical, Inc. (CLSD)

Today's Latest Price: $1.01 USD

0.06 (-5.61%)

Updated Nov 15 6:55pm

Add CLSD to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

CLSD Stock Summary

  • Clearside Biomedical Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than just 7.77% of US listed stocks.
  • CLSD's price/sales ratio is 405.92; that's higher than the P/S ratio of 99.3% of US stocks.
  • Revenue growth over the past 12 months for Clearside Biomedical Inc comes in at -42.86%, a number that bests only 4.2% of the US stocks we're tracking.
  • If you're looking for stocks that are quantitatively similar to Clearside Biomedical Inc, a group of peers worth examining would be QURE, SCYX, CRNX, RETA, and ARQL.
  • Visit CLSD's SEC page to see the company's official filings. To visit the company's web site, go to
CLSD Daily Price Range
CLSD 52-Week Price Range

CLSD Stock Price Chart More Charts

CLSD Price/Volume Stats

Current price $1.01
Prev. close $1.07
Day low $1.01
Day high $1.07
50-day MA $0.88
200-day MA $1.12
52-week high $1.92
52-week low $0.56
Volume 402,700
Avg. volume 781,565
Dividend yield N/A
Market Cap 41.56M

Clearside Biomedical, Inc. (CLSD) Company Bio

Clearside Biomedical, a biopharmaceutical company, develops drug therapies to treat chronic blinding diseases of the eye. The company was founded in 2011 and is based in Alpharetta, Georgia

CLSD Latest News Stream

Event/Time News Detail
Loading, please wait...

CLSD Latest Social Stream

Loading social stream, please wait...

View Full CLSD Social Stream

CLSD Price Returns

1-mo 21.98%
3-mo -13.68%
6-mo -15.83%
1-year -37.65%
3-year -95.62%
5-year N/A
YTD -5.61%
2018 -84.71%
2017 -21.70%
2016 N/A
2015 N/A
2014 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.5583 seconds.